Strontium ranelate: A physiological approach for optimizing bone formation and resorption

Bone

Volumn 38, Issue 2 SUPPL. 1, 2006, Pages 10-14

  Marie, P J ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bone formation; Bone resorption; Strontium ranelate

Indexed keywords

STRONTIUM RANELATE;

APOPTOSIS; CLINICAL TRIAL; DISEASE MODEL; EXPERIMENTAL MODEL; HUMAN; IMMOBILIZATION; IN VIVO STUDY; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; REVIEW;

EID: 31944442279     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.07.029     Document Type: Article

References (30)

1. G.A. Rodan, and T.J. Martin Therapeutic approaches to bone diseases Science 289 2000 1508 1514
2. B.L. Riggs, and A.M. Parfitt Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling J. Bone Miner. Res. 20 2005 177 184
3. H.J. Haüselmann, and R. Rizzoli A comprehensive review of treatments for postmenopausal osteoporosis Osteoporos. Int. 14 2003 2 12
4. S. Komatsubara, S. Mori, T. Mashiba, J. Li, K. Nonaka, and Y. Kaji Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib J. Bone Miner. Res. 19 2004 999 1005
5. T. Mashiba, C.H. Turner, T. Hirano, M.R. Forwood, C.C. Johnston, and D.B. Burr Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone 28 2001 524 531
6. T. Mashiba, C.H. Turner, T. Hirano, M.R. Forwood, D.S. Jacob, and C.C. Johnston Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures Bone 29 2001 271 278
7. C.V. Odvina, J.E. Zerwekh, D.S. Rao, N. Maalouf, F.A. Gottschalk, and C.Y. Pak Severely suppressed bone turnover: a potential complication of alendronate therapy J. Clin. Endocrinol. Metab. 90 2005 1294 1301
8. R.M. Neer, C.D. Arnaud, J.R. Zanchetta, R. Prince, G.A. Gaich, and J.Y. Reginster Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N. Engl. J. Med. 344 2001 1434 1441
9. P.J. Marie Effects of strontium on bone formation and bone cells J. Neve P. Chappuis M. Lamand Therapeutic uses of traces elements 1996 Plenum Press New York 277 282
10. P.J. Marie, P. Ammann, G. Boivin, and C. Rey Mechanisms of action and therapeutic potential of strontium in bone Calcif. Tissue Int. 69 2001 121 129
11. P.J. Marie Strontium ranelate: a novel mode of action optimizing bone formation and resorption Osteoporos. Int. 16 2005 7 10
12. N. Takahashi, T. Sasaki, Y. Tsouderos, and T. Suda S 12911-2 inhibits osteoclastic bone resorption in vitro J. Bone Miner. Res. 18 2003 1082 1087
13. R. Baron, and Y. Tsouderos In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation Eur. J. Pharmacol. 450 2002 11 17
14. A. Wattel, A. Hurtel-Lemaire, C. Godin, R. Mentaverri, S. Kamel, and M. Brazier Strontium ranelate decreases in vitro human osteoclastic differentiation Bone 36 suppl 2 2005 S400 [Abstract P585-Tu]
15. R. Mentaverri, A.S. Hurtel-Lemaire, A. Wattel, S. Kamel, E.M. Brown, and M. Brazier Calcium-sensing receptor mediates strontium ranelate-induced osteoclast apoptosis Bone 36 Suppl. 2 2005 S403 [Abstract P592-Su]
16. A.S. Hurtel-Lemaire, R. Mentaverri, A. Wattel, S. Kamel, and M. Brazier Protein kinases C are involved in strontium ranelate-induced osteoclast apoptosis Bone 36 suppl 2 2005 S401 [Abstract P586-Su]
17. S.G. Dahl, P. Allain, P.J. Marie, Y. Mauras, G. Boivin, and P. Ammann Incorporation and distribution of strontium in bone Bone 28 2001 446 453
18. E. Canalis, M. Hott, P. Deloffre, Y. Tsouderos, and P.J. Marie The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro Bone 18 1996 517 523
19. A. Barbara, P. Delannoy, B.G. Denis, and P.J. Marie Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells Metabolism 53 2004 532 537
20. E.M. Brown Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos. Int. 14 Suppl. 3 2003 S25 S34
21. J. Coulombe, H. Faure, B. Robin, and M. Ruat In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor Biochem. Biophys. Res. Commun. 323 2004 1184 1190
22. M. Pi, and L.D. Quarles A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium J. Bone Miner. Res. 19 2004 862 869
23. S. Choudhary, S. Wadhwa, L.G. Raisz, C. Alander, and C.C. Pilbeam Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway J. Bone Miner. Res. 18 2003 1813 1824
24. P. Delannoy, D. Bazot, and P.J. Marie Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice Metabolism 51 2002 906 911
25. P. Ammann, V. Shen, B. Robin, Y. Mauras, J.P. Bonjour, and R. Rizzoli Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats J. Bone Miner. Res. 19 2004 2012 2020
26. J. Buehler, P. Chappuis, J.L. Saffar, Y. Tsouderos, and A. Vignery Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis) Bone 29 2001 176 179
27. D. Modrowski, L. Miravet, M. Feuga, and P.J. Marie Increased proliferation of osteoblast precursor cells in estrogen-deficient rats Am. J. Physiol. 264 2 pt 1 1993 E190 E196
28. P.J. Marie, M. Hott, D. Modrowski, C. de Pollak, J. Guillemain, and P. Deloffre An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J. Bone Miner. Res. 8 1993 607 615
29. M. Hott, P. Deloffre, Y. Tsouderos, and P.J. Marie S12911-2 reduces bone loss induced by short-term immobilization in rats Bone 33 2003 115 123
30. P.J. Meunier, C. Roux, E. Seeman, S. Ortolani, J.E. Badurski, and T.D. Spector The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N. Engl. J. Med. 350 2004 459 468